Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naloxone for Opioid-Induced Pruritus in Children
NCT01071057Phase 3Completed
- Sponsor
- University of British Columbia
- Start
- Dec 2010
- Primary completion
- Apr 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of naloxone in opioid-induced pruritus (OIP) (2 arms), sponsored by University of British Columbia. Primary endpoints: Incidence of Opioid Induced Pruritus at 2 days and Intensity of Opioid Induced Pruritus at 2 days. Started Dec 2010; status: completed.
02
Drugs
naloxone
03
Conditions
opioid-induced pruritus (OIP)
Beyond the preview
Go deeper on NCT01071057.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01071057.